CDC and FDA Warn Dozens Sickened by Tainted "Detox" IV Drips at Wellness Clinics

The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have issued warnings after dozens of people were sickened by intravenous (IV) drip treatments marketed at wellness clinics as "detoxification" therapies, according to a report by Ars Technica.

The report states that the IV drips, intended to cleanse the body of toxins, instead contained contaminants themselves. Among the substances identified was glutathione, an antioxidant compound that, according to the report, was not manufactured or approved for intravenous injection.

Ars Technica reported that the tainted infusions have been linked to illness in dozens of people, though the exact number of cases, their locations, and the severity of symptoms were not detailed in the available source material.

The CDC and FDA's involvement suggests a coordinated federal response to the reported poisonings, though the specific nature of the agencies' warnings, recommendations for consumers, or any regulatory actions against implicated clinics or suppliers were not specified in the source excerpt.

IV "detox" treatments have grown in popularity at wellness clinics and spas in recent years, often marketed as remedies for hangovers, fatigue, or general wellness. Such treatments are typically administered outside traditional hospital settings and can involve vitamins, minerals, and other compounds delivered directly into the bloodstream.

Further details on the specific products involved, the manufacturers or clinics implicated, and any official guidance for affected patients were not available in the source material reviewed for this report.